This regulatory manner was also identified in chronic myelocytic leukemia (CML) cells, in which the alteration of LINC00470 had no effect on the luciferase activity of the PTEN promoter but affected the half-life of PTEN mRNA. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.